Mitragynine (Kratom)-induced cognitive impairments in mice resemble Δ9-THC and morphine effects: reversal by cannabinoid CB1 receptor antagonism
Kratom is a widely abused plant-based drug preparation with a global interest in recent years, well beyond its native grounds in Southeast Asia. Mitragynine, its major psychoactive constituent is known to exhibit opioid-like behavioral effects with resultant neuroplasticity in the brain reward syste...
Main Authors: | Ismail, Nurul Iman, Ahmad, Nur Aimi Zawami, Mohd Yusof, Nurul Aiman, Talib, Ummi Nasrah, Norazit, Anwar, Kumar, Jaya, Mehat, Muhammad Zulfadli, Hassan, Zurina, Muller, Christian P., Muzaimi, Mustapha |
---|---|
Format: | Article |
Published: |
Frontiers Media
2021
|
Similar Items
-
CB1 cannabinoid receptor in brain mesolimbic
system of mitragynine-sensitised albina wastar
rats as a candidate molecular terget in
mitragyna speciosa (KETUM) addiction
by: Mustapha, Muzaimi
Published: (2015) -
The combination of mitragynine and morphine prevents the development of morphine tolerance in mice
by: Fakurazi, Sharida, et al.
Published: (2013) -
Mitragynine (Kratom) impairs spatial learning and hippocampal synaptic transmission in rats
by: Hassan, Zurina, et al.
Published: (2019) -
CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain.
by: Clayton, N, et al.
Published: (2002) -
The IntelliCage system: a review of its utility as a novel behavioral platform for a rodent model of substance use disorder
by: Nurul Iman, Ismail, et al.
Published: (2021)